As such, it has become a key focus in obesity, diabetes, and weight loss medications that function by mimicking its function
No over-the-counter supplement legally contains actual GLP-1 receptor agonists, and any "GLP-1" claims on supplements are not FDA-reviewed and may be misleading
This shift reduces oxidized low-density lipoprotein uptake, inhibits foam cell formation, and is mediated predominantly through TRPV1 and PPAR signaling (64, 123)
Clinicians should recognize that patients undergoing polypharmacy require heightened vigilance, comprehensive monitoring, and specialized counseling
In the years since, peptide users have turned to a gray market, often sourcing the products from sketchy suppliers overseas